Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status

Neuroscience Bulletin

Volumn 25, Issue 6, 2009, Pages 343-352

  Kalonia, Harikesh ^a   Kumar, Puneet ^a   Kumar, Anil ^a   Nehru, Bimla ^b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Caffeic acid; Cyclooxygenase; Glutathione; Quinolinic acid; Rofecoxib

Indexed keywords

CAFFEIC ACID; GLUTATHIONE; LIPOXYGENASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROSTAGLANDIN SYNTHASE; QUINOLINIC ACID; ROFECOXIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; EXCITOTOXICITY; HUNTINGTON CHOREA; IN VIVO STUDY; MALE; MORPHOLOGY; MOTOR COORDINATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION STATE; RAT; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; CAFFEIC ACIDS; CORPUS STRIATUM; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; HUNTINGTON DISEASE; LACTONES; LIPOXYGENASE INHIBITORS; MALE; MOTOR ACTIVITY; OXIDATION-REDUCTION; QUINOLINIC ACID; RATS; RATS, WISTAR; ROTAROD PERFORMANCE TEST; SEVERITY OF ILLNESS INDEX; SULFONES; TIME FACTORS;

EID: 72349098221     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-009-0513-3     Document Type: Article

References (57)

1. M.F. Beal 1994 Neurochemistry and toxin models in Huntington's disease Curr Opin Neurol 7 6 542 547 10.1097/00019052-199412000-00012 7866587
2. P.R. Sanberg S.F. Calderon M. Giordano J.M. Tew A.B. Norman 1989 The quinolinic acid model of Huntington's disease: locomotor abnormalities Exp Neurol 105 45 53 10.1016/0014-4886(89)90170-2 2526022 (Pubitemid 19198876)
3. J.C. Furtado M.F. Mazurek 1996 Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington's disease Exp Neurol 138 1 158 168 10.1006/exnr.1996.0054 8593891 (Pubitemid 26109334)
4. R.C. Roberts A. Ahn K.J. Swartz M.F. Beal M. DiFiglia 1993 Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome Exp Neurol 124 2 274 282 10.1006/exnr.1993.1197 8287926 (Pubitemid 24041774)
5. A.B. Norman M. Giordano P.R. Sandberg 1989 Fetal striatal tissue graft into excitotoxin-lesioned striatum: pharmacological and behavioral aspects Pharmacol Biochem Behav 34 139 147 10.1016/0091-3057(89)90365-1 2626445 (Pubitemid 20008896)
6. N.C. Reynolds W. Lin C.M. Cameron D.L. Roerig 1997 Differential response of extracellular GABA to intrastriatal perfusions of 3-nitropropionic acid and quinolinic acid in the rat Brain Res 778 140 149 10.1016/S0006-8993(97)01048-2 9462886 (Pubitemid 28039897)
7. D.W. Choi 1992 Excitotoxic cell death J Neurobiol 23 9 1261 1276 10.1002/neu.480230915 1361523
8. S.D. Hurley J.A. Olschowka M.K. O'Banion 2002 Cyclooxygenase inhibition as a strategy to ameliorate brain injury J Neurotrauma 19 1 1 15 10.1089/089771502753460196 11852973
9. R.C. Kukreja H.A. Kontos M.L. Hess E.F. Ellis 1986 PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH Circ Res 59 6 612 619 3028671
10. G. Benzi A. Moretti 1995 Age- and peroxidative stress-related modifi cations of the cerebral enzymatic activities linked to mitochondria and the glutathione system Free Radic Biol Med 19 1 77 101 10.1016/0891-5849(94)00244-E 7635361
11. Cooper JL, Meister A. 1992. Glutathione in the brain: disorders of glutathione metabolism. In: Rosenberg, A. (Ed.), The Molecular and Genetic Basis of Neurological Disorders. Ruttle Graphics, New York, pp. 209-238.
12. Gerlach M, Riederer P, Youdim MBH. 1996. Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acids. In: Battistin, L., Scarlato, G., Caraceni, T., Ruggieri, S. (Eds.), Parkinsons Disease, vol. 69. Lippincott-Raven Publishers, Philadelphia, pp. 177-194.
13. J. Krieglstein 1997 Excitotoxicity and neuroprotection Eur J Pharm Sci 5 181 187 10.1016/S0928-0987(97)00276-5 (Pubitemid 27273941)
14. P. Froissard H. Monrocq D. Duval 1997 Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells Eur J Pharmacol 326 93 99 10.1016/S0014-2999(97)00155-6 9178660 (Pubitemid 27205050)
15. Kart A, Cigremis Y, Karaman M, Ozen H. Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit. Exp Toxicol Pathol 2009, 4 [Epub ahead of print].
16. D. Sul H.S. Kim D. Lee S.S. Joo K.W. Hwang S.Y. Park 2009 Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation Life Sci 84 9-10 257 262 10.1016/j.lfs.2008.12.001 19101570
17. M. Rahamathulla G. Hv N. Rathod 2008 Solubility and dissolution improvement of Rofecoxib using solid dispersion technique Pak J Pharm Sci 21 4 350 355 18930854
18. th edition: 256.
19. P. Kumar S.S. Padi P.S. Naidu A. Kumar 2007 Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms Fundam Clin Pharmacol 21 3 297 306 10.1111/j.1472-8206. 2007.00485.x 17521299 (Pubitemid 46800477)
20. Kulkarni SK. Hand book of experimental pharmacology (3rd edition). Delhi, Vallabh Prakashan, 1999.
21. G.L. Ellman 1959 Tissue sulfhydryl groups Arch Biochem Biophys 82 70 77 10.1016/0003-9861(59)90090-6 13650640
22. W.L. Zahler W.W. Cleland 1968 A specific and sensitive assay for disulfides J Biol Chem 243 716 719 5638587
23. A.G. Gornall C.J. Bardawill M.M. David 1949 Determination of serum proteins by means of the biuret reaction J Biol Chem 177 2 751 766 18110453
24. S.G. Moyanova L.V. Kortenska R.G. Mitreva V.D. Pashova R.T. Ngomba F. Nicoletti 2007 Multimodal assessment of neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia Brain Res 11 1153 58 67 10.1016/j.brainres.2007.03.070 (Pubitemid 46823888)
25. A.M. Estrada Sánchez J. Mejía-Toiber L. Massieu 2008 Excitotoxic neuronal death and the pathogenesis of Huntington's disease Arch Med Res 39 3 265 276 10.1016/j.arcmed.2007.11.011 18279698 (Pubitemid 351221151)
26. T.P. Obrenovitch 2001 Quinolinic acid accumulation during neuroinflammation. Does it imply excitotoxicity? Ann N Y Acad Sci 939 1 10 11462760
27. K. Datta S.S. Biswal J.P. Kehrer 1999 The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP Biochem J 1 340 371 375 10.1042/0264-6021:3400371 (Pubitemid 29286554)
28. A. Klegeris P.L. McGeer 2002 Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity Neurobiol Aging 23 5 787 794 10.1016/S0197-4580(02)00021-0 12392782 (Pubitemid 35217703)
29. M. Bishnoi C.S. Patil A. Kumar S.K. Kulkarni 2007 Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice Pharmacology 79 1 34 41 10.1159/000097627 17139192 (Pubitemid 46034175)
30. L. Wise-Faberowski R.D. Pearlstein D.S. Warner 2006 NMDA-induced apoptosis in mixed neuronal/glial cortical cell cultures: the effects of isoflurane and dizocilpine J Neurosurg Anesthesiol 18 4 240 246 10.1097/00008506-200610000-00004 17006121 (Pubitemid 44484229)
31. M.F. Beal R.J. Ferrante K.J. Swartz N.W. Kowall 1991 Chronic quinolinic acid lesions in rats closely resemble Huntington's disease J Neurosci 11 6 1649 1659 1710657
32. E.M. Vazey K. Chen S.M. Hughes B. Connor 2006 Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease Exp Neurol 199 2 384 396 10.1016/j.expneurol.2006.01.034 16626705 (Pubitemid 43928967)
33. C.V. Borlongan T.S. Randall D.W. Cahill P.R. Sanberg 1995 Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test Brain Res 676 231 234 10.1016/0006-8993(95) 00150-O 7796175
34. B. Picconi E. Passino C. Sgobio P. Bonsi I. Barone V. Ghiglieri, et al. 2006 Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons Neurobiol Dis 22 1 143 152 10.1016/j.nbd.2005.10.009 16326108
35. M.L. Scattoni A. Valanzano A. Pezzola Z.D. March F.R. Fusco P. Popoli, et al. 2007 Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease Behav Brain Res 176 2 216 221 10.1016/j.bbr.2006.10.004 17123640 (Pubitemid 44880086)
36. Y.M. Bordelon M.F. Chesselet M. Ereciñska I.A. Silver 1998 Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo Neuroscience 83 2 459 469 10.1016/S0306-4522(97)00421-1 9460754 (Pubitemid 28062636)
37. T.S. Tang E. Slow V. Lupu I.G. Stavrovskaya M. Sugimori R. Llinás, et al. 2005 Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease Proc Natl Acad Sci U S A 102 7 2602 2607 10.1073/pnas.0409402102 15695335 (Pubitemid 40279423)
38. Soliman D, Hamming KS, Matemisz LC, Light PE. Reactive oxygen species directly modify sodium-calcium exchanger activity in a splice variant-dependent manner. J Mol Cell Cardiol. 2009, May 27 [Epub ahead of print].
39. Nicholls DG. Mitochondrial calcium function and dysfunction in the central nervous system. Biochim Biophys Acta 2009, Mar 17 [Epub ahead of print]
40. Stanika RI, Pivovarova NB, Brantner CA, Watts CA, Winters CA, Andrews SB. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc Natl Acad Sci U S A 2009, May 29 [Epub ahead of print]
41. O. Hansson E. Guatteo N.B. Mercuri G. Bernardi X.J. Li R.F. Castilho, et al. 2001 Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene Eur J Neurosci 14 9 1492 1504 10.1046/j.0953-816x.2001.01767.x 11722611 (Pubitemid 35463716)
42. K.A. Kelley L. Ho D. Winger J. Freire-Moar C.B. Borelli P.S. Aisen, et al. 1999 Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2 Am J Pathol 155 3 995 1004 10487857
43. H. Manev T. Uz K. Sugaya T. Qu 2000 Putative role of neuronal 5-lipoxygenase in an aging brain FASEB J 14 10 1464 1469 10.1096/fj.14.10.1464 10877840
44. T.P. Misko M.K. Highkin A.W. Veenhuizen P.T. Manning M.K. Stern M.G. Currie, et al. 1998 Characterization of the cytoprotective action of peroxynitrite decomposition catalysts J Biol Chem 273 25 15646 15653 10.1074/jbc.273.25.15646 9624158 (Pubitemid 28298180)
45. L. Virág E. Szabó P. Gergely C. Szabó 2003 Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention Toxicol Lett 11 140-141 113 124 10.1016/S0378-4274(02)00508-8 (Pubitemid 36378929)
46. C. Szabó 2003 Multiple pathways of peroxynitrite cytotoxicity Toxicol Lett 11 140-141 105 112 10.1016/S0378-4274(02)00507-6 (Pubitemid 36378928)
47. D.J. Reed 1986 Regulation of reductive process by glutathione Biol Chem Pharmacol 35 7 13
48. Aries I, Jakoby WB. Glutathione metabolism and functions. Kroc Found Ser C 1976: 1-382.
49. D.J. Reed M.W. Fariss 1984 Glutathione depletion and susceptibility Pharmacol Rev 36 525 533
50. R. Munday C.C. Winterbourn 1989 Reduced glutathione in combination with superoxide dismutase as an important biological antioxidant defence mechanism Biochem Pharmacol 38 4349 4352 10.1016/0006-2952(89)90641-2 2604738 (Pubitemid 20027530)
51. C. Thifault N. Aumont R. Quirion J. Poirier 1995 Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain J Neurochem 65 2725 2733
52. J.E. Barker S.J.R. Heales A. Cassidy J.P. BolanÄ os J.M. Land J.B. Clark 1996 Depletion of brain glutathione results in a decrease of glutathione reductase, an enzyme susceptible to oxidative damage Brain Res 716 118 122 10.1016/0006-8993(96)00003-0 8738227 (Pubitemid 26156603)
53. G.N. Babu M. Bawari 1997 Single microinjection of L-glutamate induces oxidative stress in discrete regions of rat brain Biochem Mol Biol Int 43 1207 1217 9442917
54. T.H. Murphy R.L. Schnaar J.T. Coyle 1990 Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cysteine uptake FASEB J 4 1624 1633 2180770
55. C.W. Olanow 1993 A radical hypothesis for neurodegeneration Trends Neurosci 16 39 44 10.1016/0166-2236(93)90070-3 (Pubitemid 23313517)
56. C.M.F. Pereira C.R. Oliveira 1997 Glutamate toxicity on a PC12 cell line involves glutathione (GSH) depletion and oxidative stress Free Radic Biol Med 23 637 647 10.1016/S0891-5849(97)00020-8 9215809 (Pubitemid 27287347)
57. A. Kumar N. Seghal S.V. Padi P.S. Naidu 2006 Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicineinduced dysfunction and oxidative stress in rats Eur J Pharmacol 551 58 66 10.1016/j.ejphar.2006.08.076 17027965 (Pubitemid 44648058)